Yorozu Tomoko, Iijima Takehiko, Matsumoto Midori, Yeo Xing, Takagi Toshiyuki
Department of Anesthesiology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan.
J Anesth. 2007;21(2):136-41. doi: 10.1007/s00540-006-0469-7. Epub 2007 May 30.
In order to elucidate the prominent factors involved in intraoperative bradycardia in adult patients, we retrospectively investigated the association between the potential risk factors and intraoperative bradycardia, using multiple logistic regression.
The perioperative records for 499 adult patients who had undergone any of six elective surgeries were retrospectively examined. The potential factors included patient characteristics, the use of perioperative drugs for anesthesia, and the types of operational procedures. Heart rates were extracted at five points perioperatively. The frequencies and total doses of atropine injections to treat bradycardia were examined. Simple and multiple logistic regressions were used to analyze the relative risk factors for a intraoperative bradycardia.
The multiple logistic regression analysis revealed that the absence of atropine premedication was the most prominent risk factor for bradycardia (odds ratio; 1.86-5.51) from arrival in the operating room until the end of the operation. Other prominent factors, whose effects were only temporary, were as follows. Males had a higher risk of bradycardia than females upon arrival in the operating room. Surgical procedures with an epidural or subarachnoid blockade tended to have a higher risk for bradycardia after the operation. Propofol induction had a greater risk for bradycardia than thiopental after the end of the operation. Endotracheal intubation had a lower risk for bradycardia than no endotracheal intubation after induction. Vecuronium tended to induce bradycardia after operation.
The most prominent factor affecting heart rate was atropine premedication. It was noteworthy that a single preoperative administration of atropine affected heart rate throughout the operation.
为阐明成年患者术中发生心动过缓的主要相关因素,我们采用多因素逻辑回归分析,对潜在风险因素与术中心动过缓之间的关联进行了回顾性研究。
回顾性分析499例接受六种择期手术中任何一种手术的成年患者的围手术期记录。潜在因素包括患者特征、围手术期麻醉用药情况以及手术操作类型。在围手术期的五个时间点提取心率数据。检查用于治疗心动过缓的阿托品注射频率和总剂量。采用单因素和多因素逻辑回归分析术中心动过缓的相关风险因素。
多因素逻辑回归分析显示,从进入手术室到手术结束,未进行阿托品术前用药是心动过缓最显著的风险因素(比值比为1.86 - 5.51)。其他仅具有短暂影响的显著因素如下:进入手术室时,男性发生心动过缓的风险高于女性。采用硬膜外或蛛网膜下腔阻滞的手术在术后发生心动过缓的风险往往较高。手术结束后,丙泊酚诱导比硫喷妥钠诱导发生心动过缓的风险更大。诱导后,气管插管比未进行气管插管发生心动过缓的风险更低。维库溴铵在术后往往会诱发心动过缓。
影响心率的最显著因素是阿托品术前用药。值得注意的是,术前单次给予阿托品会影响整个手术过程中的心率。